Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neuromuscular Disorders : NMD|September 1, 1993
Pathological findings in 165 patients explored for malignant hyperthermia susceptibilityD Figarella-Branger, G Kozak-Ribbens, L Rodet, et al.
Acta Anaesthesiologica Scandinavica|August 19, 2004
Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermiaD Bendahan, S Guis, N Monnier, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 1, 1997
Metabolic events with spontaneous malignant hyperthermia crisis in an anaesthetized pigG Kozak-Ribbens, D Bendahan, L Rodet, et al.
Arthritis and Rheumatism|March 29, 2002
Investigation of fluoroquinolone-induced myalgia using (31)P magnetic resonance spectroscopy and in vitro contracture testsS Guis, D Bendahan, G Kozak-Ribbens, et al.
American Journal of Human Genetics|March 1, 1995
Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1R Sudbrak, V Procaccio, M Klausnitzer, et al.
Neurology|June 1, 1992
31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathiesD Bendahan, C Desnuelle, D Vanuxem, et al.
Arthritis and Rheumatism|July 29, 2006
In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effectsS Guis, D Figarella-Branger, J P Mattei, et al.
European Journal of Human Genetics : EJHG|April 18, 2003
Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?R L Robinson, M J Anetseder, V Brancadoro, et al.
Acta Anaesthesiologica Scandinavica|October 6, 1997
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia GroupH Ording, V Brancadoro, S Cozzolino, et al.
Pageof 2